Macquarie Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $59.3M | Sell |
273,227
-712,817
| -72% | -$158M | 0.35% | 59 |
|
|
2025
Q4 | $225M | Buy |
986,044
+51,559
| +6% | +$11.7M | 0.98% | 14 |
|
|
2025
Q3 | $216M | Buy |
934,485
+337,911
| +57% | +$68.8M | 0.25% | 61 |
|
|
2025
Q2 | $111M | Sell |
596,574
-210,412
| -26% | -$39.1M | 0.14% | 204 |
|
|
2025
Q1 | $169M | Buy |
806,986
+84,265
| +12% | +$16.4M | 0.21% | 107 |
|
|
2024
Q4 | $116M | Buy |
722,721
+196,709
| +37% | +$36.2M | 0.14% | 204 |
|
|
2024
Q3 | $104M | Buy |
526,012
+25,858
| +5% | +$4.83M | 0.11% | 251 |
|
|
2024
Q2 | $85.8M | Buy |
500,154
+56,229
| +13% | +$9.31M | 0.1% | 267 |
|
|
2024
Q1 | $80.8M | Sell |
443,925
-71,668
| -14% | -$12.4M | 0.09% | 282 |
|
|
2023
Q4 | $79.9M | Sell |
515,593
-248,602
| -33% | -$36.2M | 0.09% | 300 |
|
|
2023
Q3 | $74.4M | Buy |
764,195
+323,367
| +73% | +$47.5M | 0.09% | 292 |
|
|
2023
Q2 | $59.4M | Sell |
440,828
-67,809
| -13% | -$9.94M | 0.07% | 377 |
|
|
2023
Q1 | $81.1M | Buy |
508,637
+52,064
| +11% | +$7.96M | 0.1% | 282 |
|
|
2022
Q4 | $73.8M | Buy |
456,573
+18,881
| +4% | +$2.9M | 0.09% | 323 |
|
|
2022
Q3 | $58.7M | Sell |
437,692
-31,065
| -7% | -$4.46M | 0.07% | 374 |
|
|
2022
Q2 | $71.8M | Sell |
468,757
-104,976
| -18% | -$16M | 0.08% | 339 |
|
|
2022
Q1 | $93K | Sell |
573,733
-161,885
| -22% | -$23.5M | 0.07% | 314 |
|
|
2021
Q4 | $99.6M | Sell |
735,618
-23,294
| -3% | -$2.75M | 0.08% | 305 |
|
|
2021
Q3 | $81.9M | Sell |
758,912
-135,931
| -15% | -$15.5M | 0.07% | 363 |
|
|
2021
Q2 | $101M | Sell |
894,843
-74,827
| -8% | -$8.43M | 0.08% | 302 |
|
|
2021
Q1 | $105M | Buy |
969,670
+297,561
| +44% | +$31.8M | 0.15% | 147 |
|
|
2020
Q4 | $72M | Buy |
672,109
+124,760
| +23% | +$12M | 0.11% | 218 |
|
|
2020
Q3 | $47.9M | Buy |
547,349
+112,365
| +26% | +$10.6M | 0.08% | 277 |
|
|
2020
Q2 | $42.7M | Buy |
434,984
+140,866
| +48% | +$12.4M | 0.07% | 286 |
|
|
2020
Q1 | $22.4M | Buy |
294,118
+126,981
| +76% | +$10.8M | 0.05% | 387 |
|
|
2019
Q4 | $14.8M | Sell |
167,137
-2,798
| -2% | -$232K | 0.02% | 579 |
|
|
2019
Q3 | $12.9M | Sell |
169,935
-73,287
| -30% | -$5.02M | 0.02% | 545 |
|
|
2019
Q2 | $17.7M | Sell |
243,222
-11,680
| -5% | -$918K | 0.03% | 484 |
|
|
2019
Q1 | $20.5M | Sell |
254,902
-3,780
| -1% | -$309K | 0.04% | 457 |
|
|
2018
Q4 | $23.8M | Sell |
258,682
-154,986
| -37% | -$13.6M | 0.05% | 384 |
|
|
2018
Q3 | $39.1M | Sell |
413,668
-28,620
| -6% | -$2.71M | 0.06% | 319 |
|
|
2018
Q2 | $41M | Buy |
442,288
+12,938
| +3% | +$1.26M | 0.07% | 307 |
|
|
2018
Q1 | $40.6M | Sell |
429,350
-51,316
| -11% | -$5.64M | 0.07% | 280 |
|
|
2017
Q4 | $46.6M | Buy |
480,666
+143,538
| +43% | +$13.5M | 0.08% | 233 |
|
|
2017
Q3 | $30M | Sell |
337,128
-31,691
| -9% | -$2.41M | 0.05% | 359 |
|
|
2017
Q2 | $26.7M | Buy |
368,819
+28,384
| +8% | +$1.91M | 0.05% | 377 |
|
|
2017
Q1 | $22.2M | Sell |
340,435
-123,470
| -27% | -$7.76M | 0.04% | 432 |
|
|
2016
Q4 | $29M | Sell |
463,905
-361,030
| -44% | -$22M | 0.06% | 321 |
|
|
2016
Q3 | $52M | Sell |
824,935
-601,359
| -42% | -$38.9M | 0.1% | 168 |
|
|
2016
Q2 | $88.3M | Buy |
1,426,294
+687,029
| +93% | +$41.9M | 0.09% | 192 |
|
|
2016
Q1 | $42.2M | Sell |
739,265
-1,570
| -0.2% | -$87.5K | 0.09% | 201 |
|
|
2015
Q4 | $43.9M | Buy |
740,835
+138,539
| +23% | +$7.98M | 0.09% | 203 |
|
|
2015
Q3 | $32.8M | Buy |
602,296
+49,006
| +9% | +$3.19M | 0.07% | 252 |
|
|
2015
Q2 | $37.2M | Sell |
553,290
-162,550
| -23% | -$10.6M | 0.07% | 249 |
|
|
2015
Q1 | $41.9M | Sell |
715,840
-75,864
| -10% | -$4.58M | 0.08% | 239 |
|
|
2014
Q4 | $51.8M | Sell |
791,704
-38,749
| -5% | -$2.44M | 0.11% | 186 |
|
|
2014
Q3 | $48M | Sell |
830,453
-13,128
| -2% | -$729K | 0.1% | 182 |
|
|
2014
Q2 | $47.6M | Sell |
843,581
-69,645
| -8% | -$3.65M | 0.11% | 185 |
|
|
2014
Q1 | $46.9M | Buy |
913,226
+117,470
| +15% | +$5.94M | 0.08% | 182 |
|
|
2013
Q4 | $42M | Buy |
795,756
+95,029
| +14% | +$4.67M | 0.08% | 194 |
|
|
2013
Q3 | $31.3M | Buy |
700,727
+11,792
| +2% | +$523K | 0.06% | 241 |
|
|
2013
Q2 | $28.5M | Buy |
+688,935
| New | +$30.1M | 0.06% | 243 |
|
Other funds holding ABBV
VCM
VPM
Macquarie Group's ABBV Position: Q1 2026 in Review
Macquarie Group reduced its AbbVie (ABBV) stake by 72% in Q1 2026, selling an estimated $158M and leaving 273,227 shares worth $59.3M. The position accounts for 0.35% of the portfolio, ranked #59.
Macquarie Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $225M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Macquarie Group held 273,227 shares of AbbVie worth $59.3M as of Q1 2026.
- Macquarie Group sold 712,817 AbbVie shares in Q1 2026, an estimated $158M.
- AbbVie made up 0.35% of Macquarie Group's portfolio in Q1 2026, its #59 holding.
- Macquarie Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Macquarie Group's AbbVie position peaked at $225M in Q4 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.